This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Nuclear Medicine Equipment Market

Nuclear Medicine Equipment Market – Analysis, Outlook, Growth Trends, and Forecast

Nuclear Medicine Equipment Market Analysis by Product , Application, End User & Region - Forecast 2022 - 2032

Nuclear Medicine Equipment Market Outlook (2022-2032)

[342 Pages Report] The nuclear medical equipment market is estimated to grow at a stable CAGR of 4.1% between 2022 and 2032. The market for nuclear medical equipment is expected to expand from US$ 2.3 Billion in 2022 to US$ 3.4 Billion in 2032, supported by:

  • The increasing frequency of cancer and cardiovascular illness, as well as the growing need for image-guided operations and diagnostics.
  • Rising SPECT and PET applications, as well as rising public awareness of healthcare, are likely to boost the market in the next years.
  • Nuclear medicine's success may be attributed to the fact that it provides a unique and non-invasive access to information at the molecular and cellular levels that other imaging technologies cannot imitate.
  • Increased diagnostic nuclear medicine operations will assist to boost nuclear medicine equipment demand forward in the approaching years.
  • Radiopharmaceutical use in diagnostics is expanding at a rate of more than 10% per year worldwide. Reduced funding for medical imaging, a lack of cost-effectiveness statistics and evidence to show that nuclear medicine improves patient outcomes, and a lack of anatomic and molecular imaging training among physicians and radiologists are all likely to slow the growth of the nuclear medicine equipment market.

During the COVID-19 pandemic, there was a decline in traditional nuclear imaging operations in electric surgery for cardiovascular disorders and cancer diagnosis. As a result, demand for a variety of equipment, including SPECT, has fallen. This has had a detrimental impact on the nuclear medical equipment market forecast.

During the pandemic, hospitals and healthcare institutions throughout the world postponed non-elective treatments in order to focus on treating the large number of corona virus patients. As a result, the use of nuclear medical equipment has declined.

Data Points

Key Statistics

Expected Market Value in 2022

US$ 2.3 Billion

Projected Market Value in 2032

US$ 3.4 Billion

Growth Rate (2016-2026)

4.1% CAGR

Customize this Report

Let us know your requirement to get
100% FREE customization

Development of Nuclear Medicine Equipment Market in the North America

Nuclear medicine equipment’s primary market is North America. The United States is one of the main radioisotope consumer markets in North America, and Canada is one of the primary manufacturers of Tc-99m.

The robust growth of the healthcare sector in the United States, rising cancer incidences, a growing geriatric population, and an increase in product launches leading to increased use of radioisotopes, as well as increased initiatives and investments in advanced cancer treatment, are expected to drive market growth.

Opportunities abound in the Hospital Segment

The hospital sector will account for the largest nuclear medicine equipment market share during the forecast period 2022-2032, owing to increased healthcare spending by emerging global economies and the presence of highly established and sophisticated healthcare infrastructure in developed nations.

Furthermore, the rise in lifestyle conditions such as cardiovascular disease and cancer has increased the target patient population as well as the need for early identification and treatment by hospitals worldwide.

Because of the rise in lifestyle diseases, governmental and corporate organisations have increased their investment in Research Centers, making this the fastest growing sector with a CAGR of 4.8%. The market for nuclear medical equipment is expanding.

As per nuclear medicine equipment market study, the nuclear medicine's success can be ascribed to the fact that it supplies a unique and non-invasive approach to information at the molecular and cellular level that is unique and cannot be replicated by other imaging technologies.

It also aids in the early detection of sickness and is one of the market's most favourable drivers, as public awareness of chronic diseases grows. Increased diagnostic nuclear medicine procedures around the world will help to propel the demand for nuclear medicine equipment forward in the coming years.

According to supporting data, the usage of radiopharmaceuticals in diagnostics is increasing at a rate of over 10% per year over the world. Reduced funding for medical imaging, a lack of cost-effectiveness statistics and evidence to prove that nuclear medicine improves patient outcomes, and a dearth of anatomic and molecular imaging training among physicians and radiologists are all likely to slow the nuclear medicine equipment market expansion.

The adoption of nuclear medicine equipment has been rising at a rapid rate, which is both stimulating and boosting the market for nuclear medical equipment. Furthermore, the growing awareness of the necessity of early disease diagnosis, as well as the high acceptance of nuclear medicine equipment by end users, leads the nuclear medicine equipment market to have a high adoption rate among the patients.

Increased investment in diagnostic imaging centre renovations, as well as the development of new radiotracers, will additionally fuel demand for nuclear medicine equipment. The constant development of new and upgraded goods is also having a significant impact on the nuclear medicine equipment market size.

Through the emerging trends in the nuclear medicine equipment market, a long-term product pipeline, rising disease incidence among the ageing population, and increased demand for nuclear medical operations are all contributing to the said market growth.

While the prohibitive cost of nuclear medicine equipment and reduced half-life radiopharmaceuticals, as well as a lack of effective data and proof that nuclear medicine improves patient outcomes, are projected to stymie the target market's growth throughout the forecast period. Furthermore, the introduction of new and sophisticated goods is boosting the sales of nuclear medicine equipment.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What Is Propelling The Nuclear Medicine Equipment Market?

Nuclear imaging system advancements are expected to boost product demand for nuclear medicine equipment. Nuclear imaging technologies such as PET and SPECT have advanced to the point where they can now be employed in fields other than oncology, cardiology, and neurology.

For example, the introduction of SPECT detectors based on cadmium zinc telluride has aided in the simultaneous viewing of physiological and anatomical systems. During the forecast period, this will drive global demand for nuclear medicine equipment.

What Restrains The Nuclear Medicine Equipment Market?

In developing regions, a lack of research facilities and funding is expected to stifle the nuclear medicine equipment market growth.

Because of a lack of adequate funding in developing countries, even basic nuclear medicine equipment like as phantoms is becoming scarce. It has also slowed the expansion of medical research centres and radiation-protection technology.

Furthermore, the average cost of patient healthcare in poor countries is 1000 times lower than in affluent countries like the United States. As a result, hospitals have little motivation to invest in costly nuclear medicine equipment. This is reducing the market opportunities for sales of nuclear medicine equipment.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

What Are The Trends In The Nuclear Medicine Equipment Market?

The market for nuclear medicine equipment is expected to be fuelled by an increase in the prevalence of the target patient population.

Cancer alone claimed the lives of approximately 10 million people globally, according to the World Health Organization (WHO). Both the developed and developing worlds are expected to see a rise in cancer cases.

It is expected that one out of every nine Indians will develop cancer at some point in their lives. Heart disease is the leading cause of death worldwide, accounting for 16 percent of all deaths. Early detection increases the odds of survival dramatically, and nuclear medicine equipment plays a critical part in this. This has led to a rapid rise in the adoption of nuclear medicine equipment.

Comparative View Of Adjacent Nuclear Medicine Equipment Market

Nuclear Medicine Equipment Market:

Attributes

Nuclear Medicine Equipment Market

CAGR (2022-2032)

4.1%

Market Value (2026)

US$ 3.4 Billion

Growth Factor

The market growth is expected to be fuelled by an increase in the prevalence of the target patient population.

Opportunity

Nuclear imaging system advancements are expected to enhance the market growth.

Key Trends

The growing awareness of the necessity of early disease diagnosis, as well as the high acceptance of nuclear medicine equipment by end users, leads the demand for nuclear medicine equipment to have a high adoption rate.

Nuclear Medicine Market:

Attributes

Nuclear Medicine Market

CAGR (2022-2032)

9%

Market Value (2026)

US$ 7.5 Billion

Growth Factor

Increasing the incidence and prevalence of cancer and heart disease, as well as measures to close the Mo-99 demand-supply imbalance is driving the market.

Opportunity

Neurological implications of radiopharmaceuticals are opening new horizons in the market.

Key Trends

Radiopharmaceuticals' short half-life limits their potential adoption, while hospital budget cuts and costly equipment expenses are projected to impede market growth.

Radiation Detection, Monitoring, & Safety Market:

Attributes

Radiation Detection, Monitoring, & Safety Market

CAGR (2022-2032)

6.9%

Market Value (2026)

US$ 3.1 Billion

Growth Factor

Increasing security dangers, global cancer prevalence, and increased radiation safety awareness are leading the market.

Opportunity

Increased use of nuclear medicine and radiation therapy for diagnosis and treatment, as well as an increase in the number of PET/CT scans.

Key Trends

The market for homeland security applications will be fuelled by rising military spending.

Geographically, North America was expected to have the highest nuclear medicine equipment market share in 2020, and it is expected to continue to dominate the market over the forecast period of 2021-2026, owing to the region's highly developed healthcare system and growing target patient population.

Globally, lifestyle disorders like as cancer and cardiovascular ailments are expected to boost the market trends, but the Covid-19 epidemic led to slow down in the growth of demand for nuclear medicine equipment, as patients are afraid of infection, resulting in fewer hospital visits.

Which Is The Leading Segment In The Nuclear Medicine Equipment Market By End User?

During the projection period 2021-2026, the hospital sector will account for the biggest nuclear medicine equipment market share, owing to rising healthcare spending by emerging global economies and the presence of highly established and advanced healthcare infrastructure in developed countries.

Furthermore, the rise in lifestyle disorders such as cardiovascular disease and cancer has led in an increase in the target patient population and a demand for early detection and treatment by hospitals around the world.

As a result of the increase in lifestyle illnesses, governmental and private entities have boosted their investment in Research Centers, making this area the fastest expanding with a CAGR of 4.8 percent. The nuclear medicine equipment market opportunities are on the rise.

Which Is The Leading Segment In The Nuclear Medicine Equipment Market By Product Type?

The SPECT segment was forecasted to dominate the said market in 2020, and it is expected to continue to do so with a CAGR of 4.7 percent over the forecast period. This is because it is used in a wide range of applications and is also quite inexpensive. Another aspect driving the segment's rise is the surge in technical advancement.

In the category, innovation has resulted in the creation of digital SPECT, which supplies more image detail and sensitivity. Because of its ability to generate 3D images and correct full-body scans, the Hybrid PET segment is expected to increase at the fastest rate during the forecast period. SPECT segment leads the nuclear medicine equipment market with the projected CAGR of 4.92% by 2032.

Regional Insights

Which is the Leading Region in the Nuclear Medicine Equipment Market?

North America is a significant regional segment due to the rapid rise of nuclear medicine in the United States because of technical advancements. Furthermore, North America's supremacy is due to the quick release of new radiopharmaceuticals for diagnostics and therapies.

During the projected period, Asia Pacific, on the other hand, is expected to increase at the fastest rate. In the Asia Pacific, Japan has the largest consumer nuclear medicine equipment market.

The practise of nuclear medicine in Japan has advanced significantly in recent years, with a significant increase in the frequency of hybrid SPECT/CT exams. Furthermore, rising demand for Alzheimer's and Parkinson's disease treatment and diagnostics in China and India is fuelling the Asia Pacific sales of nuclear medicine equipment.

Regions

CAGR (2022-2032)

United States

3.7%

United Kingdom

3.3%

China

3.6%

Japan

2.7%

South Korea

2.4%

How Market Competition is Influencing the Nuclear Medicine Equipment Regional Presence?

To increase their market share, key players in the worldwide are focusing on new product launches. Product launches, product approvals, and other organic growth tactics such as patents and events are being prioritised by several companies.

Acquisitions, as well as partnerships and collaborations, were seen as inorganic growth tactics in the target market. These initiatives have paved the road for market players to expand their business and client base and change the nuclear medicine equipment market outlook.

Some of the recent developments in the Nuclear Medicine Equipment market are:

  • Curium bought the Austrian radiopharmaceutical business IASON in June 2021 to boost its diagnostic product line's European footprint.
  • PYLARIFY injectable was approved by the Food and Drug Administration (FDA) in May 2021 by Lantheus, a US diagnostic imaging agents and equipment firm. The injection is the first PSMA PET imaging agent for prostate cancer that is commercially accessible.

Key players

  • Philips Healthcare
  • GE Healthcare
  • Siemens Healthineers AG
  • Digirad Corporation
  • Mediso Medical Imaging Systems Ltd
  • DDD-Diagnostics A/S
  • Neusoft Medical Systems Co. Ltd.
  • SurgicEye GmbH
  • CMR Naviscan Corporation

Key Segments

By Product:

  • SPECT
    • Hybrid SPECT
    • Standalone SPECT
  • Hybrid PET
  • Planar Scintigraphy

By Application:

  • Oncology
  • Cardiology
  • Neurology
  • Others

By End User:

  • Hospitals
  • Imaging Centers
  • Academic & Research Institutes
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • MEA
  • Latin America

Frequently Asked Questions

The Nuclear Medicine Equipment market is projected to have a CAGR of 4.1% in 2032.

North America is the leading region, with an anticipated CAGR of 3.7% by 2032.

Oncology leads the Nuclear Medicine Equipment market with the projected CAGR of 4.3% by 2032.

The Nuclear Medicine Equipment market is predicted to grow US$ 3.4 Billion by 2032.

SPECT segment leads the market with the projected CAGR of 4.92% by 2032.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on Demand

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background

    4.1. Market, by Key Countries

    4.2. Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking

6. Global Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Product

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Product, 2015-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022-2032

        8.3.1. SPECT

            8.3.1.1. Hybrid SPECT

            8.3.1.2. Standalone SPECT

        8.3.2. Hybrid PET

        8.3.3. Planar Scintigraphy

    8.4. Market Attractiveness Analysis By Product

9. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Application

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Application, 2015-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2032

        9.3.1. Oncology

        9.3.2. Cardiology

        9.3.3. Neurology

        9.3.4. Others (Orthopedics, Urology, Thyroid Related Disorders, and Gastroenterology)

    9.4. Market Attractiveness Analysis By Application

10. Global Market Analysis 2015-2021 and Forecast 2022-2032, By End User

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2032

        10.3.1. Hospitals

        10.3.2. Imaging Centers

        10.3.3. Academic & Research Institutes

        10.3.4. Others (Pharma/Biotech companies, and CROs)

    10.4. Market Attractiveness Analysis By End User

11. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

    11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. Asia Pacific

        11.3.5. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Market Analysis 2015-2021 and Forecast 2022-2032

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        12.4.1. By Country

            12.4.1.1. U.S.

            12.4.1.2. Canada

            12.4.1.3. Rest of North America

        12.4.2. By Product

        12.4.3. By End User

        12.4.4. By Application

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Product

        12.5.3. By End User

        12.5.4. By Application

13. Latin America Market Analysis 2015-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. Brazil

            13.4.1.2. Mexico

            13.4.1.3. Rest of Latin America

        13.4.2. By Product

        13.4.3. By End User

        13.4.4. By Application

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Product

        13.5.3. By End User

        13.5.4. By Application

14. Europe Market Analysis 2015-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. Germany

            14.4.1.2. France

            14.4.1.3. U.K.

            14.4.1.4. Italy

            14.4.1.5. Benelux

            14.4.1.6. Nordic Countries

            14.4.1.7. Rest of Europe

        14.4.2. By Product

        14.4.3. By End User

        14.4.4. By Application

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Product

        14.5.3. By End User

        14.5.4. By Application

15. Asia Pacific Market Analysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        15.4.1. By Country

            15.4.1.1. China

            15.4.1.2. Japan

            15.4.1.3. South Korea

            15.4.1.4. Rest of Asia Pacific

        15.4.2. By Product

        15.4.3. By End User

        15.4.4. By Application

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Product

        15.5.3. By End User

        15.5.4. By Application

16. Middle East and Africa Market Analysis 2015-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        16.4.1. By Country

            16.4.1.1. GCC Countries

            16.4.1.2. South Africa

            16.4.1.3. Turkey

            16.4.1.4. Rest of Middle East and Africa

        16.4.2. By Product

        16.4.3. By End User

        16.4.4. By Application

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Product

        16.5.3. By End User

        16.5.4. By Application

17. Key Countries Market Analysis 2015-2021 and Forecast 2022-2032

    17.1. Introduction

        17.1.1. Market Value Proportion Analysis, By Key Countries

        17.1.2. Global Vs. Country Growth Comparison

    17.2. US Market Analysis

        17.2.1. Value Proportion Analysis by Market Taxonomy

        17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            17.2.2.1. By Product

            17.2.2.2. By End User

            17.2.2.3. By Application

    17.3. Canada Market Analysis

        17.3.1. Value Proportion Analysis by Market Taxonomy

        17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            17.3.2.1. By Product

            17.3.2.2. By End User

            17.3.2.3. By Application

    17.4. Mexico Market Analysis

        17.4.1. Value Proportion Analysis by Market Taxonomy

        17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            17.4.2.1. By Product

            17.4.2.2. By End User

            17.4.2.3. By Application

    17.5. Brazil Market Analysis

        17.5.1. Value Proportion Analysis by Market Taxonomy

        17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            17.5.2.1. By Product

            17.5.2.2. By End User

            17.5.2.3. By Application

    17.6. Germany Market Analysis

        17.6.1. Value Proportion Analysis by Market Taxonomy

        17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            17.6.2.1. By Product

            17.6.2.2. By End User

            17.6.2.3. By Application

    17.7. France Market Analysis

        17.7.1. Value Proportion Analysis by Market Taxonomy

        17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            17.7.2.1. By Product

            17.7.2.2. By End User

            17.7.2.3. By Application

    17.8. Italy Market Analysis

        17.8.1. Value Proportion Analysis by Market Taxonomy

        17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            17.8.2.1. By Product

            17.8.2.2. By End User

            17.8.2.3. By Application

    17.9. BENELUX Market Analysis

        17.9.1. Value Proportion Analysis by Market Taxonomy

        17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            17.9.2.1. By Product

            17.9.2.2. By End User

            17.9.2.3. By Application

    17.10. UK Market Analysis

        17.10.1. Value Proportion Analysis by Market Taxonomy

        17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            17.10.2.1. By Product

            17.10.2.2. By End User

            17.10.2.3. By Application

    17.11. Nordic Countries Market Analysis

        17.11.1. Value Proportion Analysis by Market Taxonomy

        17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            17.11.2.1. By Product

            17.11.2.2. By End User

            17.11.2.3. By Application

    17.12. China Market Analysis

        17.12.1. Value Proportion Analysis by Market Taxonomy

        17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            17.12.2.1. By Product

            17.12.2.2. By End User

            17.12.2.3. By Application

    17.13. Japan Market Analysis

        17.13.1. Value Proportion Analysis by Market Taxonomy

        17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            17.13.2.1. By Product

            17.13.2.2. By End User

            17.13.2.3. By Application

    17.14. South Korea Market Analysis

        17.14.1. Value Proportion Analysis by Market Taxonomy

        17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            17.14.2.1. By Product

            17.14.2.2. By End User

            17.14.2.3. By Application

    17.15. GCC Countries Market Analysis

        17.15.1. Value Proportion Analysis by Market Taxonomy

        17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            17.15.2.1. By Product

            17.15.2.2. By End User

            17.15.2.3. By Application

    17.16. South Africa Market Analysis

        17.16.1. Value Proportion Analysis by Market Taxonomy

        17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            17.16.2.1. By Product

            17.16.2.2. By End User

            17.16.2.3. By Application

    17.17. Turkey Market Analysis

        17.17.1. Value Proportion Analysis by Market Taxonomy

        17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032

            17.17.2.1. By Product

            17.17.2.2. By End User

            17.17.2.3. By Application

        17.17.3. Competition Landscape and Player Concentration in the Country

18. Market Structure Analysis

    18.1. Market Analysis by Tier of Companies

    18.2. Market Concentration

    18.3. Market Share Analysis of Top Players

    18.4. Market Presence Analysis

        18.4.1. By Regional footprint of Players

        18.4.2. Product footprint by Players

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Competition Deep Dive

        19.3.1. Philips Healthcare

            19.3.1.1. Overview

            19.3.1.2. Product Portfolio

            19.3.1.3. Sales Footprint

            19.3.1.4. Strategy Overview

        19.3.2. GE Healthcare

            19.3.2.1. Overview

            19.3.2.2. Product Portfolio

            19.3.2.3. Sales Footprint

            19.3.2.4. Strategy Overview

        19.3.3. Siemens Healthineers AG

            19.3.3.1. Overview

            19.3.3.2. Product Portfolio

            19.3.3.3. Sales Footprint

            19.3.3.4. Strategy Overview

        19.3.4. Digirad Corporation

            19.3.4.1. Overview

            19.3.4.2. Product Portfolio

            19.3.4.3. Sales Footprint

            19.3.4.4. Strategy Overview

        19.3.5. Mediso Medical Imaging Systems, Ltd.

            19.3.5.1. Overview

            19.3.5.2. Product Portfolio

            19.3.5.3. Sales Footprint

            19.3.5.4. Strategy Overview

        19.3.6. DDD-Diagnostics A/S

        19.3.7. Neusoft Medical Systems Co. Ltd.

            19.3.7.1. Overview

            19.3.7.2. Product Portfolio

            19.3.7.3. Sales Footprint

            19.3.7.4. Strategy Overview

        19.3.8. SurgicEye GmbH

            19.3.8.1. Overview

            19.3.8.2. Product Portfolio

            19.3.8.3. Sales Footprint

            19.3.8.4. Strategy Overview

        19.3.9. CMR Naviscan Corporation

            19.3.9.1. Overview

            19.3.9.2. Product Portfolio

            19.3.9.3. Sales Footprint

            19.3.9.4. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Market Value (US$ Mn), By Product, 2015 – 2032

Table 2: Global Market Value (US$ Mn), By Product, 2022 – 2032

Table 3: Global Market Value (US$ Mn), By End User, 2015 – 2032

Table 4: Global Market Value (US$ Mn), By End User, 2022 – 2032

Table 5: Global Market Value (US$ Mn), By Application, 2015 – 2032

Table 6: Global Market Value (US$ Mn), By Application, 2022 – 2032

Table 7: Global Market, By Region, 2015 – 2032

Table 8: Global Market, By Region, 2022 – 2032

Table 9: North America Market Value (US$ Mn), By Product, 2015 – 2032

Table 10: North America Market Value (US$ Mn), By Product, 2022 – 2032

Table 11: North America Market Value (US$ Mn), By End User, 2015 – 2032

Table 12: North America Market Value (US$ Mn), By End User, 2022 – 2032

Table 13: North America Market Value (US$ Mn), By Application, 2015 – 2032

Table 14: North America Market Value (US$ Mn), By Application, 2022 – 2032

Table 15: North America Market, By Country, 2015 – 2032

Table 16: North America Market, By Country, 2022 – 2032

Table 17: Latin America Market Value (US$ Mn), By Product, 2015 – 2032

Table 18: Latin America Market Value (US$ Mn), By Product, 2022 – 2032

Table 19: Latin America Market Value (US$ Mn), By End User, 2015 – 2032

Table 20: Latin America Market Value (US$ Mn), By End User, 2022 – 2032

Table 21: Latin America Market Value (US$ Mn), By Application, 2015 – 2032

Table 22: Latin America Market Value (US$ Mn), By Application, 2022 – 2032

Table 23: Latin America Market, By Country, 2015 – 2032

Table 24: Latin America Market, By Country, 2022 – 2032

Table 25: Europe Market Value (US$ Mn), By Product, 2015 – 2032

Table 26: Europe Market Value (US$ Mn), By Product, 2022 – 2032

Table 27: Europe Market Value (US$ Mn), By End User, 2015 – 2032

Table 28: Europe Market Value (US$ Mn), By End User, 2022 – 2032

Table 29: Europe Market Value (US$ Mn), By Application, 2015 – 2032

Table 30: Europe Market Value (US$ Mn), By Application, 2022 – 2032

Table 31: Europe Market, By Country, 2015 – 2032

Table 32: Europe Market, By Country, 2022 – 2032

Table 33: Asia Pacific Market Value (US$ Mn), By Product, 2015 – 2032

Table 34: Asia Pacific Market Value (US$ Mn), By Product, 2022 – 2032

Table 35: Asia Pacific Market Value (US$ Mn), By End User, 2015 – 2032

Table 36: Asia Pacific Market Value (US$ Mn), By End User, 2022 – 2032

Table 37: Asia Pacific Market Value (US$ Mn), By Application, 2015 – 2032

Table 38: Asia Pacific Market Value (US$ Mn), By Application, 2022 – 2032

Table 39: Asia Pacific Market, By Country, 2015 – 2032

Table 40: Asia Pacific Market, By Country, 2022 – 2032

Table 41: MEA Market Value (US$ Mn), By Product, 2015 – 2032

Table 42: MEA Market Value (US$ Mn), By Product, 2022 – 2032

Table 43: MEA Market Value (US$ Mn), By End User, 2015 – 2032

Table 44: MEA Market Value (US$ Mn), By End User, 2022 – 2032

Table 45: MEA Market Value (US$ Mn), By Application, 2015 – 2032

Table 46: MEA Market Value (US$ Mn), By Application, 2022 – 2032

Table 47: MEA Market, By Country, 2015 – 2032

Table 48: MEA Market, By Country, 2022 – 2032

Table 49: Global Market Incremental $ Opportunity, By Product, 2022 – 2032

Table 50: Global Market Incremental $ Opportunity, By End User, 2022 – 2032

Table 51: Global Market Incremental $ Opportunity, By Application, 2022 – 2032

Table 52: Global Market Incremental $ Opportunity, By Region, 2022 – 2032

Table 53: North America Market Incremental $ Opportunity, By Product, 2022 – 2032

Table 54: North America Market Incremental $ Opportunity, By End User, 2022 – 2032

Table 55: North America Market Incremental $ Opportunity, By Application, 2022 – 2032

Table 56: North America Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 57: Latin America Market Incremental $ Opportunity, By Product, 2022 – 2032

Table 58: Latin America Market Incremental $ Opportunity, By End User, 2022 – 2032

Table 59: Latin America Market Incremental $ Opportunity, By Application, 2022 – 2032

Table 60: Latin America Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 61: Europe Market Incremental $ Opportunity, By Product, 2022 – 2032

Table 62: Europe Market Incremental $ Opportunity, By End User, 2022 – 2032

Table 63: Europe Market Incremental $ Opportunity, By Application, 2022 – 2032

Table 64: Europe Market Incremental $ Opportunity, By Country, 2022 - 2032

Table 65: Asia Pacific Market Incremental $ Opportunity, By Product, 2022 – 2032

Table 66: Asia Pacific Market Incremental $ Opportunity, By End User, 2022 – 2032

Table 67: Asia Pacific Market Incremental $ Opportunity, By Application, 2022 – 2032

Table 68: Asia Pacific Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 69: MEA Market Incremental $ Opportunity, By Product, 2022 – 2032

Table 70: MEA Market Incremental $ Opportunity, By End User, 2022 – 2032

Table 71: MEA Market Incremental $ Opportunity, By Application, 2022 – 2032

Table 72: MEA Market Incremental $ Opportunity, By Country, 2022 - 2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ Mn) and Year-on-Year Growth, 2022-2032

Figure 2: Global Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global Market Share, By Product, 2021 & 2032

Figure 4: Global Market Y-o-Y Growth Projections, By Product – 2022-2032

Figure 5: Global Market Attractiveness Index, By Product – 2022-2032

Figure 6: Global Market Share, By End User, 2021 & 2032

Figure 7: Global Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 8: Global Market Attractiveness Index, By End User – 2022-2032

Figure 9: Global Market Share, By Application, 2021 & 2032

Figure 10: Global Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 11: Global Market Attractiveness Index, By Application – 2022-2032

Figure 12: Global Market Share, By Region, 2021 & 2032

Figure 13: Global Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 14: Global Market Attractiveness Index, By Region – 2022-2032

Figure 15: North America Market Value (US$ Mn) and Year-on-Year Growth, 2022-2032

Figure 16: North America Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 17: North America Market Share, By Product, 2021 & 2032

Figure 18: North America Market Y-o-Y Growth Projections, By Product – 2022-2032

Figure 19: North America Market Attractiveness Index, By Product – 2022-2032

Figure 20: North America Market Share, By End User, 2021 & 2032

Figure 21: North America Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 22: North America Market Attractiveness Index, By End User – 2022-2032

Figure 23: North America Market Share, By Application, 2021 & 2032

Figure 24: North America Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 25: North America Market Attractiveness Index, By Application – 2022-2032

Figure 26: North America Market Share, By Country, 2021 & 2032

Figure 27: North America Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 28: North America Market Attractiveness Index, By Country – 2022-2032

Figure 29: Latin America Market Value (US$ Mn) and Year-on-Year Growth, 2022-2032

Figure 30: Latin America Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 31: Latin America Market Share, By Product, 2021 & 2032

Figure 32: Latin America Market Y-o-Y Growth Projections, By Product – 2022-2032

Figure 33: Latin America Market Attractiveness Index, By Product – 2022-2032

Figure 34: Latin America Market Share, By End User, 2021 & 2032

Figure 35: Latin America Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 36: Latin America Market Attractiveness Index, By End User – 2022-2032

Figure 37: Latin America Market Share, By Application, 2021 & 2032

Figure 38: Latin America Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 39: Latin America Market Attractiveness Index, By Application – 2022-2032

Figure 40: Latin America Market Share, By Country, 2021 & 2032

Figure 41: Latin America Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 42: Latin America Market Attractiveness Index, By Country – 2022-2032

Figure 43: Europe Market Value (US$ Mn) and Year-on-Year Growth, 2022-2032

Figure 44: Europe Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 45: Europe Market Share, By Product, 2021 & 2032

Figure 46: Europe Market Y-o-Y Growth Projections, By Product – 2022-2032

Figure 47: Europe Market Attractiveness Index, By Product – 2022-2032

Figure 48: Europe Market Share, By End User, 2021 & 2032

Figure 49: Europe Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 50: Europe Market Attractiveness Index, By End User – 2022-2032

Figure 51: Europe Market Share, By Application, 2021 & 2032

Figure 52: Europe Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 53: Europe Market Attractiveness Index, By Application – 2022-2032

Figure 54: Europe Market Share, By Country, 2021 & 2032

Figure 55: Europe Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 56: Europe Market Attractiveness Index, By Country – 2022-2032

Figure 57: MEA Market Value (US$ Mn) and Year-on-Year Growth, 2022-2032

Figure 58: MEA Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 59: MEA Market Share, By Product, 2021 & 2032

Figure 60: MEA Market Y-o-Y Growth Projections, By Product – 2022-2032

Figure 61: MEA Market Attractiveness Index, By Product – 2022-2032

Figure 62: MEA Market Share, By End User, 2021 & 2032

Figure 63: MEA Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 64: MEA Market Attractiveness Index, By End User – 2022-2032

Figure 65: MEA Market Share, By Application, 2021 & 2032

Figure 66: MEA Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 67: MEA Market Attractiveness Index, By Application – 2022-2032

Figure 68: MEA Market Share, By Country, 2021 & 2032

Figure 69: MEA Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 70: MEA Market Attractiveness Index, By Country – 2022-2032

Figure 71: Asia Pacific Market Value (US$ Mn) and Year-on-Year Growth, 2022-2032

Figure 72: Asia Pacific Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 73: Asia Pacific Market Share, By Product, 2021 & 2032

Figure 74: Asia Pacific Market Y-o-Y Growth Projections, By Product – 2022-2032

Figure 75: Asia Pacific Market Attractiveness Index, By Product – 2022-2032

Figure 76: Asia Pacific Market Share, By End User, 2021 & 2032

Figure 77: Asia Pacific Market Y-o-Y Growth Projections, By End User – 2022-2032

Figure 78: Asia Pacific Market Attractiveness Index, By End User – 2022-2032

Figure 79: Asia Pacific Market Share, By Application, 2021 & 2032

Figure 80: Asia Pacific Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 81: Asia Pacific Market Attractiveness Index, By Application – 2022-2032

Figure 82: Asia Pacific Market Share, By Country, 2021 & 2032

Figure 83: Asia Pacific Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 84: Asia Pacific Market Attractiveness Index, By Country – 2022-2032

Figure 85: US Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 86: US Market Share, By Product, 2021 & 2032

Figure 87: US Market Share, By End User, 2021 & 2032

Figure 88: US Market Share, By Application, 2021 & 2032

Figure 89: Canada Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 90: Canada Market Share, By Product, 2021 & 2032

Figure 91: Canada Market Share, By End User, 2021 & 2032

Figure 92: Canada Market Share, By Application, 2021 & 2032

Figure 93: Brazil Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 94: Brazil Market Share, By Product, 2021 & 2032

Figure 95: Brazil Market Share, By End User, 2021 & 2032

Figure 96: Brazil Market Share, By Application, 2021 & 2032

Figure 97: Mexico Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 98: Mexico Market Share, By Product, 2021 & 2032

Figure 99: Mexico Market Share, By End User, 2021 & 2032

Figure 100: Mexico Market Share, By Application, 2021 & 2032

Figure 101: Germany Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 102: Germany Market Share, By Product, 2021 & 2032

Figure 103: Germany Market Share, By End User, 2021 & 2032

Figure 104: Germany Market Share, By Application, 2021 & 2032

Figure 105: U.K. Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 106: U.K. Market Share, By Product, 2021 & 2032

Figure 107: U.K. Market Share, By End User, 2021 & 2032

Figure 108: U.K. Market Share, By Application, 2021 & 2032

Figure 109: France Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 110: France Market Share, By Product, 2021 & 2032

Figure 111: France Market Share, By End User, 2021 & 2032

Figure 112: France Market Share, By Application, 2021 & 2032

Figure 113: Italy Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 114: Italy Market Share, By Product, 2021 & 2032

Figure 115: Italy Market Share, By End User, 2021 & 2032

Figure 116: Italy Market Share, By Application, 2021 & 2032

Figure 117: BENELUX Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 118: BENELUX Market Share, By Product, 2021 & 2032

Figure 119: BENELUX Market Share, By End User, 2021 & 2032

Figure 120: BENELUX Market Share, By Application, 2021 & 2032

Figure 121: Nordic Countries Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 122: Nordic Countries Market Share, By Product, 2021 & 2032

Figure 123: Nordic Countries Market Share, By End User, 2021 & 2032

Figure 124: Nordic Countries Market Share, By Application, 2021 & 2032

Figure 125: China Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 126: China Market Share, By Product, 2021 & 2032

Figure 127: China Market Share, By End User, 2021 & 2032

Figure 128: China Market Share, By Application, 2021 & 2032

Figure 129: Japan Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 130: Japan Market Share, By Product, 2021 & 2032

Figure 131: Japan Market Share, By End User, 2021 & 2032

Figure 132: Japan Market Share, By Application, 2021 & 2032

Figure 133: South Korea Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 134: South Korea Market Share, By Product, 2021 & 2032

Figure 135: South Korea Market Share, By End User, 2021 & 2032

Figure 136: South Korea Market Share, By Application, 2021 & 2032

Figure 137: GCC Countries Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 138: GCC Countries Market Share, By Product, 2021 & 2032

Figure 139: GCC Countries Market Share, By End User, 2021 & 2032

Figure 140: GCC Countries Market Share, By Application, 2021 & 2032

Figure 141: South Africa Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 142: South Africa Market Share, By Product, 2021 & 2032

Figure 143: South Africa Market Share, By End User, 2021 & 2032

Figure 144: South Africa Market Share, By Application, 2021 & 2032

Figure 145: Turkey Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 146: Turkey Market Share, By Product, 2021 & 2032

Figure 147: Turkey Market Share, By End User, 2021 & 2032

Figure 148: Turkey Market Share, By Application, 2021 & 2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Nuclear Export Inhibitor Drugs Market

Published : September 2020

Healthcare

Therapeutic Nuclear Medicines Market

Published : March 2022

Healthcare

Personalized Medicine Market

Published : May 2016

Healthcare

Nuclear Imaging Devices Market

Published : February 2022

Google translate

Nuclear Medicine Equipment Market